MedTrace Logo

Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia

NCT06250712 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 588

Last updated 2026-07-21

No results posted yet for this study

Summary

The HELP-A study is a multicenter, randomized, controlled trial. A total of 588 patients were enrolled during the 4-year enrollment period and followed for 1 month. This study aims to compare the diagnostic yield of a continuous ECG patch versus an intermittent handheld ECG in patients with arrhythmia symptoms.

Conditions

Interventions

DEVICE

Continous ECG Patch

Using a continuous patch ECG for 1 week during 1 month

DEVICE

Intermittent handheld ECG

Using a handheld ECG twice daily and when symptoms are present during 1 month

Sponsors & Collaborators

  • Wonju Severance Christian Hospital

    lead OTHER

Principal Investigators

  • Young Jun Park, MD · Wonju Severance Christian Hopsital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-22
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06250712 on ClinicalTrials.gov